Earnings summaries and quarterly performance for Quanterix.
Executive leadership at Quanterix.
Board of directors at Quanterix.
Research analysts who have asked questions during Quanterix earnings calls.
Daniel Brennan
TD Cowen
3 questions for QTRX
Also covers: A, ADPT, AVTR +24 more
Kyle Mikson
Canaccord Genuity
3 questions for QTRX
Also covers: AKYA, BDSX, CSTL +12 more
Puneet Souda
Leerink Partners
3 questions for QTRX
Also covers: A, ABCL, BRKR +20 more
Sung Ji Nam
Scotiabank
3 questions for QTRX
Also covers: ADPT, BDSX, BNGO +9 more
Matthew Sykes
Goldman Sachs Group Inc.
2 questions for QTRX
Also covers: A, ADPT, AVTR +21 more
Thomas DeBourcy
Nephron Research
2 questions for QTRX
Also covers: CDNA, NEOG, TWST +2 more
Jake Allen
Goldman Sachs
1 question for QTRX
Also covers: PACB
Michael Cherny
Leerink Partners
1 question for QTRX
Also covers: ACCD, ALGN, CAH +18 more
Recent press releases and 8-K filings for QTRX.
Quanterix Announces Board and Leadership Changes
QTRX
Board Change
Management Change
Hiring
- Quanterix Corporation announced significant board and leadership changes, effective November 20, 2025, to support its next stage of growth.
- Paul Meister and David Walt, Ph.D., retired from the Board of Directors.
- The Board appointed Garret Hampton, Ph.D., and Alan Sachs, M.D., Ph.D., as new directors. Dr. Hampton will serve on the Audit and Compensation Committees, and Dr. Sachs will serve on the Compensation Committee.
- Bill Donnelly was appointed Executive Chair of the Board, and Jeffrey Elliott was appointed Lead Independent Director.
- Following these changes, the Quanterix Board now comprises nine members, with seven being independent.
Nov 20, 2025, 10:22 PM
Quanterix Reports Q3 2025 Results and Integration Progress
QTRX
Earnings
Guidance Update
M&A
- Quanterix reported $40.2 million in total revenue for Q3 2025, representing a 12% increase year over year, with Simoa contributing $23 million and Spatial $17.2 million.
- The company has realized $67 million of its $85 million in targeted cost synergies following the Akoya acquisition.
- Quanterix expects to finish 2025 with approximately $120 million in cash and no debt, and anticipates being cash flow breakeven in 2026.
- The full-year 2025 revenue guidance remains unchanged at $130-$135 million, with a pro forma revenue of $165-$170 million if the companies were combined for the full year.
- Significant R&D investments, totaling approximately $27 million year-to-date, are focused on Alzheimer's diagnostics and new assays, with an early access program for Simoa ONE planned.
Nov 10, 2025, 9:30 PM
Quanterix Reports Q3 2025 Results and Provides 2025 Guidance
QTRX
Earnings
Guidance Update
M&A
- Quanterix reported Q3 2025 revenue of $40.2 million, marking a 12% increase compared to Q3 2024.
- The company provided full-year 2025 revenue guidance of $130 million to $135 million and expects GAAP and Adjusted Gross Margin to be between 45% to 47%.
- Quanterix anticipates ending 2025 with approximately $120 million of cash and no debt.
- Through Akoya integration, the company expects $85 million in synergy and cost actions in 2026, aiming for cash flow breakeven performance in 2026, with $67 million of these annualized cost reductions already implemented.
Nov 10, 2025, 9:30 PM
Quanterix Reports Q3 2025 Financial Results
QTRX
Earnings
Guidance Update
M&A
- Quanterix Corporation reported Q3 2025 revenue of $40.2 million, an increase of 12.3% compared to the prior year.
- The company's GAAP gross margin for Q3 2025 was 42.8%, with an Adjusted EBITDA (non-GAAP) loss of $11.9 million.
- Quanterix ended the third quarter with $138.1 million in cash, cash equivalents, marketable securities, and restricted cash, and anticipates ending 2025 with approximately $120 million.
- The company reaffirmed its 2025 revenue guidance of $130 to $135 million and expects to achieve cash flow break-even in 2026, driven by $67 million in cost synergies already implemented from the Akoya integration.
Nov 10, 2025, 9:08 PM
QT Imaging Secures Funding to Repurchase Warrants
QTRX
Debt Issuance
Share Buyback
- QT Imaging Holdings, Inc. received $5.0 million in new funding from Lynrock Lake Master Fund LP.
- This financing was obtained through a restated and amended senior secured term loan.
- The net proceeds were used to repurchase and cancel all warrants held by YA II PN, Ltd. (Yorkville).
- These warrants represented 15,000,000 shares of the Company’s Common Stock at an exercise price of $0.40 per share.
- QT Imaging's CEO, Dr. Raluca Dinu, stated that the transaction reflects confidence in the business's future outlook and is believed to enhance long-term shareholder value.
Aug 27, 2025, 12:30 PM
Quarterly earnings call transcripts for Quanterix.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more